- Status:
- Topic selection
- Technology type:
- Medicine
- Decision:
- Not selected
- Reason for decision:
- Not eligible for Health Technology Evaluation guidance
- Further information:
- Decision makers have concluded that this technology will not progress as a potential technology appraisal (TA) or a highly specialised technology (HST) as is not a new active substance and already a racemic mixture of the same active substance (Zopiclone) already being used therefore, there would be no value in a TA.
- ID number:
- 12020
Project Team
- Project lead
- Danielle Lees
Email enquiries
If you have any queries please email [email protected]
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
11 July 2024 | Topic selection |
For further information on how we select topics for development, please see our page about prioritising our guidance topics